IRS1 and breast carcinoma: These and previous findings identify IRS-1 as a key signalling component for both IGF-IR and erbB receptor tyrosine kinases in ER+ breast cancer cells and as an important convergence point for cross-talk between these two receptor tyrosine kinase families.